Celanese to Close Two European Manufacturing Facilities
Tue, December 10 2013
Employee consultation process completed at Roussillon,
These consultations have resulted in negotiated and approved redundancy
and social plans for the affected employees. The social plans include
measures aimed at minimizing the effects of the facility closures on the
workforces at Roussillon and
The company will cease all manufacturing operations and associated
activities at the acetic anhydride plant in Roussillon and at the vinyl
acetate monomer (VAM) unit in
As a result of the Roussillon site closure and the Tarragona VAM unit
closure, Celanese expects to record personnel-related exit costs and
other facility-related shutdown costs in the range of
The need for these closure projects emerged from an assessment of Celanese’s overall corporate strategy, which included an assessment of the company’s global manufacturing facilities. Specifically, in support of the company’s acetyl portfolio, the manufacturing footprint strategy favors integrated production sites that provide critical economies of scale.
About Celanese
All registered trademarks are owned by
Forward-Looking Statements
This release may contain “forward-looking statements,” which include
information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, and other information that
is not historical information. When used in this release, the
words “estimates,” “expects,” “anticipates,” “projects,” “plans,”
“intends,” “believes,” and variations of such words or similar
expressions are intended to identify forward-looking statements. All
forward-looking statements are based upon current expectations and
beliefs and various assumptions. There can be no assurance that
the company will realize these expectations or that these beliefs will
prove correct. There are a number of risks and uncertainties that
could cause actual results to differ materially from the forward-looking
statements contained in this release. Numerous factors, many of
which are beyond the company’s control, could cause actual results to
differ materially from those expressed as forward-looking statements.
Other risk factors include those that are discussed in the company’s
filings with the
Investor Relations
Jon.Puckett@celanese.com
or
Media
–
William.Jacobsen@celanese.com
or
Media
–
J.Kurth@celanese.com
Source: